Diversa Corporation
The development of enzymes and other biologically active compounds; Among these are orally active drugs, produced by these genes and gene pathways.
Diversa was founded in 1994 as Recombinant Biocatalysis, Inc. by Barry L. Marrs.
Edward T. Shonsey (CEO)
Anthony E. Altig (CFO)
James H. Cavanaugh, Ph.D. (Chairman)
Peter Johnson
Fernand Kaufmann, Ph.D.
Mark Leschly
Melvin I. Simon, Ph.D.
Cheryl A. Wenzinger
4955 Directors Place
San Diego, CA 92121-1609
USA
Phone: +1-858-526-5000
Fax: +1-858-526-5551
GigaMatrix™ is a ultra high-throughput screening platform.
Related news
- Diversa and Celunol Announce Merger to Create a New Biofuels Industry Leader
- Diversa Corporation to Host Conference Call with Simultaneous Webcast
- Diversa Corporation to Present at Upcoming Investment Conferences With Simultaneous Webcasts
- Diversa Corporation to Present at the 2006 UBS Global Life Sciences Conference With Simultaneous Webcast
- Diversa Corporation to Announce Second Quarter and Mid-Year Financial Results and Provide Guidance
- Diversa Reports Financial Results for the Quarter and Year Ended December 31, 2005
- Diversa Corporation to Announce Fourth Quarter and Full-Year Financial Results and Provide Guidance